CD40-GEX(Glycotope)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCD40-GEX(Glycotope)

Drug Alias NameCD40-GEX

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 inhibitorsAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes stimulants

TargetsTumor necrosis factor receptor superfamily member 5

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGlycotope Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesGlycotope Gmbh

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A